DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine
20 août 2008 12h52 HE
|
DelSite, Inc.
* First Nasal Powder Vaccine Against Bird Flu
* Moving to Clinical Development Stage
* Platform Suitable for Pandemic Preparedness and Epidemic Control
* Significant...
DelSite Biotechnologies Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute
18 août 2008 12h37 HE
|
DelSite, Inc.
* Third Annual Immunotherapeutics and Vaccine Summit
* New Approach to Vaccine Delivery
* Significant advantages over Current Vaccine Technologies
* Lead Product Candidate-GelVac(tm) Nasal...
DelSite Reports Second Quarter 2008 Results
14 août 2008 10h16 HE
|
DelSite, Inc.
Company Fully Focused On Commercial Development
of Vaccine, Drug Delivery and Adjuvant Technologies
Conference Call Scheduled for 4:30 pm Eastern Today
IRVING, Texas,...
DelSite Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection
04 août 2008 12h31 HE
|
DelSite, Inc.
* Sabila Industrial ISO-Certified for More Than Five Years
* No Significant Incidences of Nonconformance Found
* Continued Dedication to Quality
IRVING, Texas, Aug....
DelSite Sells Wound Care Division to Medline Industries
31 juil. 2008 10h55 HE
|
DelSite, Inc.
IRVING, Texas, July 31, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTCBB:DSII), a drug and vaccine delivery technology company, today announced it has entered into an agreement to sell its Carrington(r)...
DelSite's New Stock Symbol is DSII.OB
31 juil. 2008 07h59 HE
|
DelSite, Inc.
IRVING, Texas, July 31, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTCBB:CARN) (OTCBB:DSII), a drug and vaccine delivery technology company, said its common shares will trade on the OTCBB under the new...
DelSite Advances Nasal Delivery of Therapeutic Peptide
15 juil. 2008 10h11 HE
|
DelSite, Inc.
-- GelVac(tm) Nasal Powder Platform Delivers Peptide
Arginine-Vasopressin (AVP) Into Systemic Circulation
-- Peptide Widely Used to Control Urine Output in Patients With
Diabetes...
Carrington Laboratories, Inc. Changes Its Name to DelSite, Inc.
08 juil. 2008 08h59 HE
|
DelSite, Inc.
IRVING, Texas, July 8, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTC:CARN) officially became the name of Carrington Laboratories, Inc. on June 30, 2008. The name change was approved by the company's...
DelSite Biotechnologies Announces Master Service Agreement With Accelovance, Inc. for Clinical Services
26 juin 2008 12h44 HE
|
DelSite, Inc.
* First Nasal Powder H5N1 Influenza Vaccine Candidate
* Distinct Advantages for Pandemic Preparedness
* Phase I Dose-Escalating Study
IRVING, Texas, June 26,...
DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate
26 juin 2008 08h59 HE
|
DelSite, Inc.
* Safer and More Economical Approach Against a Major Infectious
Disease That Causes 500,000 to 600,000 Deaths Worldwide Per Year
* Chemical Composition Similar to Marketed Typhoid...